Skip to main content
Top
Published in: BMC Oral Health 1/2020

Open Access 01-12-2020 | Immunodeficiency | Case report

Oral management of a patient with down syndrome and agammaglobulinemia: a case report

Authors: Yasuka Kusumoto, Kohsuke Imai, Yoshio Ohyama, Haruhisa Fukayama, Osamu Shinozuka

Published in: BMC Oral Health | Issue 1/2020

Login to get access

Abstract

Background

Down syndrome is characterized by a variety of dysmorphic features and congenital malformations, such as congenital heart disease, gastrointestinal disease, and other conditions like leukemia and autoimmune disorders. Patients with Down syndrome are highly prone to respiratory tract infections, which might be fatal to them. However, there are only few available data on patients diagnosed with Down syndrome and agammaglobulinemia. In this report, we describe a case of successful prevention of post-dental treatment complications (e.g., pneumonia and other bacterial infections) in a patient with Down syndrome and agammaglobulinemia.

Case presentation

A 43-year-old man with Down syndrome, untreated agammaglobulinemia, and a history of recurrent pneumonia, was referred to our clinic for tooth mobility. To reduce the risk of post-operative infections, gammaglobulin treatment and prophylactic administration of antibiotics was scheduled before the dental procedure. Furthermore, the dental treatment, which included a filling and extractions, was conducted under general anesthesia and with the supervision of a hematologist. The dental procedures were successfully performed without any post-operative infection, and the patient is undergoing follow-up care.

Conclusions

The purpose of this case report was to recommend a close liaison between physicians and dentists who may encounter a similar case, and to emphasize the importance of improving oral health of immunodeficient patients to prevent infections caused by oral microbial flora.
Literature
1.
go back to reference Bloemers BL, Broers CJ, Bont L, Weijerman ME, Gemke RJ, van Furth AM. Increased risk of respiratory tract infections in children with Down syndrome: the consequence of an altered immune system. Microbes Infect. 2010;12:799–08.CrossRef Bloemers BL, Broers CJ, Bont L, Weijerman ME, Gemke RJ, van Furth AM. Increased risk of respiratory tract infections in children with Down syndrome: the consequence of an altered immune system. Microbes Infect. 2010;12:799–08.CrossRef
2.
go back to reference Pérez JAH, Hernandez Guerra JS. Community-acquired pneumonia in adults with Down syndrome. Three clinical cases and a review of the literature. Rev Med Int Sindr Down. 2010;14:25–30.CrossRef Pérez JAH, Hernandez Guerra JS. Community-acquired pneumonia in adults with Down syndrome. Three clinical cases and a review of the literature. Rev Med Int Sindr Down. 2010;14:25–30.CrossRef
3.
4.
go back to reference Ram G, Chinen J. Infections and immunodeficiency in Down syndrome. Clin Exp Immunol. 2011;164:9–16.CrossRef Ram G, Chinen J. Infections and immunodeficiency in Down syndrome. Clin Exp Immunol. 2011;164:9–16.CrossRef
5.
go back to reference Kusters MA, Verstegen RH, Gemen EF, de Vries E. Intrinsic defect of the immune system in children with Down syndrome: a review. Clin Exp Immunol. 2009;156:189–93.CrossRef Kusters MA, Verstegen RH, Gemen EF, de Vries E. Intrinsic defect of the immune system in children with Down syndrome: a review. Clin Exp Immunol. 2009;156:189–93.CrossRef
6.
go back to reference Furst DE. Serum immunoglobulins and risk of infection: how low can you go? Semin Arthritis Rheum. 2008;39:18–29.CrossRef Furst DE. Serum immunoglobulins and risk of infection: how low can you go? Semin Arthritis Rheum. 2008;39:18–29.CrossRef
7.
go back to reference Aghamohammadi A, Moin M, Farhoudi A, Rezaei N, Pourpak Z, Movahedi M, et al. Efficacy of intravenous immunoglobulin on the prevention of pneumonia in patients with agammaglobulinemia. FEMS Immunol Microbiol. 2004;40:113–8.CrossRef Aghamohammadi A, Moin M, Farhoudi A, Rezaei N, Pourpak Z, Movahedi M, et al. Efficacy of intravenous immunoglobulin on the prevention of pneumonia in patients with agammaglobulinemia. FEMS Immunol Microbiol. 2004;40:113–8.CrossRef
10.
go back to reference Driessen G, van der Burg M. Educational paper: primary antibody deficiencies. Eur J Pediatr. 2011;170:693–02.CrossRef Driessen G, van der Burg M. Educational paper: primary antibody deficiencies. Eur J Pediatr. 2011;170:693–02.CrossRef
11.
go back to reference Pilcher E. Dental care for the patient with Down syndrome. Down Syndr Res Practice. 1998;5:111–6.CrossRef Pilcher E. Dental care for the patient with Down syndrome. Down Syndr Res Practice. 1998;5:111–6.CrossRef
12.
go back to reference Bloemers BL, van Bleek GM, Kimpen JL, Bont L. Distinct abnormalities in the innate immune system of children with Down syndrome. J Pediatr. 2010;156:804–9.CrossRef Bloemers BL, van Bleek GM, Kimpen JL, Bont L. Distinct abnormalities in the innate immune system of children with Down syndrome. J Pediatr. 2010;156:804–9.CrossRef
13.
go back to reference Shehata N, Palda V, Bowen T, Haddad E, Issekutz TB, Mazer B, et al. The use of immunoglobulin therapy for patients with primary immune deficiency. An evidence-based practice guideline. Transfus Med Rev. 2010;24:S28–50.CrossRef Shehata N, Palda V, Bowen T, Haddad E, Issekutz TB, Mazer B, et al. The use of immunoglobulin therapy for patients with primary immune deficiency. An evidence-based practice guideline. Transfus Med Rev. 2010;24:S28–50.CrossRef
14.
go back to reference Kwan A, Abraham RS, Currier R, Brower A, Andruszewski K, Abbott JK, et al. Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States. JAMA. 2014;312:729–38.CrossRef Kwan A, Abraham RS, Currier R, Brower A, Andruszewski K, Abbott JK, et al. Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States. JAMA. 2014;312:729–38.CrossRef
15.
go back to reference Kamae C, Nakagawa N, Sato H, Honma K, Mitsuiki N, Ohara O, et al. Common variable immunodeficiency classification by quantifying T-cell receptor and immunoglobulin κ-deleting recombination excision circles. J Allergy Clin Immunol. 2013;131:1437–40 e5.CrossRef Kamae C, Nakagawa N, Sato H, Honma K, Mitsuiki N, Ohara O, et al. Common variable immunodeficiency classification by quantifying T-cell receptor and immunoglobulin κ-deleting recombination excision circles. J Allergy Clin Immunol. 2013;131:1437–40 e5.CrossRef
16.
go back to reference Nakagawa N, Imai K, Kanegane H, Sato H, Yamada M, Kondoh K, et al. Quantification of k-deleting recombination excision circles in Guthrie cards for the identification of early B-cell maturation defects. J Allergy Clin Immunol. 2011;128:223–5e2.CrossRef Nakagawa N, Imai K, Kanegane H, Sato H, Yamada M, Kondoh K, et al. Quantification of k-deleting recombination excision circles in Guthrie cards for the identification of early B-cell maturation defects. J Allergy Clin Immunol. 2011;128:223–5e2.CrossRef
17.
go back to reference Michela B, Annika O, Stephan B, Susanne J, Rolf HZ, Jovanka K, et al. Newborn screening for severe primary immunodeficiency diseases in Sweden—a 2-year pilot TREC and KREC screening study. J Clin Immunol. 2017;37:51–60.CrossRef Michela B, Annika O, Stephan B, Susanne J, Rolf HZ, Jovanka K, et al. Newborn screening for severe primary immunodeficiency diseases in Sweden—a 2-year pilot TREC and KREC screening study. J Clin Immunol. 2017;37:51–60.CrossRef
Metadata
Title
Oral management of a patient with down syndrome and agammaglobulinemia: a case report
Authors
Yasuka Kusumoto
Kohsuke Imai
Yoshio Ohyama
Haruhisa Fukayama
Osamu Shinozuka
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Oral Health / Issue 1/2020
Electronic ISSN: 1472-6831
DOI
https://doi.org/10.1186/s12903-020-1056-2

Other articles of this Issue 1/2020

BMC Oral Health 1/2020 Go to the issue